Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Benjamin Guy Bitler

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bitler, Benjamin

Item TypeName
Concept Cell Line, Tumor
Academic Article Intracellular MUC1 peptides inhibit cancer progression.
Academic Article MUC1 regulates nuclear localization and function of the epidermal growth factor receptor.
Academic Article ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
Academic Article The Primary Effect on the Proteome of ARID1A-mutated Ovarian Clear Cell Carcinoma is Downregulation of the Mevalonate Pathway at the Post-transcriptional Level.
Academic Article Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
Academic Article MUC1 drives c-Met-dependent migration and scattering.
Academic Article BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.
Academic Article NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells.
Academic Article Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
Academic Article BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.
Academic Article ARID1A-mutated ovarian cancers depend on HDAC6?activity.
Academic Article BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer.
Academic Article CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.
Academic Article The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Academic Article SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells.
Academic Article Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel.
Academic Article Activation of Wnt signaling promotes olaparib resistant ovarian cancer.
Academic Article Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.
Academic Article Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations.
Academic Article Wnt family member 4 (WNT4) and WNT3A activate cell-autonomous Wnt signaling independent of porcupine O-acyltransferase or Wnt secretion.
Academic Article Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
Academic Article Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy.
Academic Article Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression.
Academic Article Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Academic Article The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.
Academic Article ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
Academic Article TWEAK-Fn14-RelB Signaling Cascade Promotes Stem Cell-like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse.
Academic Article Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma.
Academic Article CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.

Search Criteria
  • Cell Line Tumor

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)